Tailoring malaria control
Local levels of strain diversity influence patterns of antimalarial drug resistance in different regions of the world.
Drug resistance among strains of the parasites that cause malaria is a growing problem for people relying on antimalarial drugs to protect them from the disease. This phenomenon is global yet exactly how resistance emerges, spreads and persists in a population often differs greatly between regions, which can complicate malaria control projects. For example, discontinuing the use of antimalarials can lead to the frequency of resistant strains declining in an area, such as Africa, but persisting at high levels in others, including Asia and South America.
Gaining resistance often leads to parasites becoming less transmissible than other strains. When antimalarials are not used, sensitive strains usually outcompete their resistant counterparts. However, prolonged use of antimalarial drugs tends to eliminate susceptible strains, allowing the previously outcompeted resistant strains to dominate. The local dynamics of antimalarial resistance are also shaped by multiple other factors such as transmission levels (how common the disease is in the region), the type of antimalarial measures used (such as drugs and mosquito nets), or previous immunity the population may have developed to specific strains. While many computational models have been developed to capture these dynamics, they usually fail to include strain diversity — a parameter reflecting the number of malaria strains the immune system is exposed to. This parameter is important as parasites need to escape both host immunity and drugs in order to be successful.
To address this gap, He, Chaillet, and Labbé created a computational model to investigate how strain diversity, transmission levels and other related factors influence antimalarial resistance. The model was used to explore how the frequency of resistant and susceptible strains changes over time once antimalarial drugs are rolled out and then halted. These analyses show that in areas with both low strain diversity and low transmission levels, susceptible parasites are more likely to be wiped out from the population, leading to a high frequency of resistant strains that persist after drugs are discontinued. However, in high diversity and high transmission regions, susceptible strains can remain in the population. Therefore, when drug treatments are stopped, resistance levels are more likely to drop due to these parasites outcompeting the drug-resistant ones.
Overall, this work demonstrates how modelling approaches that include strain diversity can help inform public health decisions aimed at reducing antimalarial resistance. In particular, they can provide important insights into the control strategies that are best suited for a specific region, suggesting that in low transmission areas intensive drug treatment may contribute to resistance. Instead, preventative strategies such as eliminating mosquitos and preventing bites with bed nets may prove more beneficial at reducing transmission rates in such areas.
Originally published at https://elifesciences.org/digests/90888.
